NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/06/2025
Voltar para busca
Dado oficial do USPTO
EIBIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
13/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 10
Data de depósito
14/09/2020
Data de registro
12/07/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/07/2022
Última transação
13/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
FITZSIMONS,MICHAEL R
Unidade examinadora
L30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
AgPlus Diagnostics Ltd
Representantes
Robert P. Felber, Jr. Waller Lansden Dortch & Davis, LLP
Classificação técnica
Classes Nice
Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer software for measuring analyte concentrations for use with medical devicesveterinary devicesmedical measurement devicesclinical measurement devicesenvironmental medical devices; downloadable computer software for measuring analyte concentrations for use with medical devicesveterinary devicesmeasurement devicesclinical measurement devicesenvironmental medical devices; downloadable computer application software for measuring analyte concentrations for use with medical devicesveterinary devicesmeasurement devicesclinical measurement devicesenvironmental medical devices; downloadable computer software applications for measuring analyte concentrations for use with medical devicesveterinary devicesmeasurement devicesclinical measurement devicesenvironmental medical devices
Classe 10
Medical devices for medical diagnostics in clinical application sectorspoint of care diagnostic devices for ascertaining clinically relevant measurements of analyte concentration in whole bloodblood serumblood plasmaurinefaecessputum and interstitial fluid for use in human and veterinary testing; diagnostic apparatus for medical purposespoint of care diagnostic medical devices for ascertaining clinically relevant measurements of analyte concentration in whole bloodblood serumblood plasmaurinefaecessputum and interstitial fluid; diagnostic instruments for medical usepoint of care diagnostic platforms in the nature of medical diagnostic instruments for testing whole bloodblood serumblood plasmaurinefaecessputum and interstitial fluidincorporating recorded software for ascertaining clinically relevant measurements of analyte concentration; medical diagnostic testing apparatus for use in immunoassay procedures; medical diagnostic testing instruments for use in immunoassay procedure; immunological analysers being diagnostic apparatus for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/07/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/06/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/11/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/10/2022
FIMP
FINAL DISPOSITION PROCESSED
18/10/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/10/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/08/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/07/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/07/2022
GPNX
NOTIFICATION PROCESSED BY IB
03/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/04/2022
PUBO
PUBLISHED FOR OPPOSITION
26/04/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
17/04/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/04/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/04/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/03/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
30/03/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/03/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
21/03/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/03/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
21/03/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/03/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
18/03/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/03/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
18/03/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/03/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
20/09/2021
GNFR
FINAL REFUSAL E-MAILED
20/09/2021
CNFR
FINAL REFUSAL WRITTEN
20/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/08/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/08/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/08/2021
RFNT
REFUSAL PROCESSED BY IB
07/03/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/02/2021
RFRR
REFUSAL PROCESSED BY MPU
18/02/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/02/2021
CNRT
NON-FINAL ACTION WRITTEN
06/02/2021
DOCK
ASSIGNED TO EXAMINER
26/01/2021
MAFR
APPLICATION FILING RECEIPT MAILED
03/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/10/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/10/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EIBIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.